Home > Insider Trading > Filing (0000014272-15-000243)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
14272	Bristol Myers Squibb Co	BMY	Pharmaceutical Preparations (2834)	220790350

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1208099	Lamberto Andreotti	Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.10 Par Value	Disposition	2015-12-14	11,300	$67.99	344,752	No	4	S	Direct
Common Stock, $0.10 Par Value	Disposition	2015-12-14	300	$68.52	344,452	No	4	S	Direct
Common Stock, $0.10 Par Value	Disposition	2015-12-15	11,600	$70.05	332,852	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.10 Par Value	100,000	Indirect	2015 Trust

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2015.
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $67.44 to $68.295, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $68.44 to $68.575, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.46 to $70.43, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.